 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
Welcome to The Alliance for Fertility Preservation's 2016
Special Delivery!
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
You are receiving this correspondence because of your personal or professional interest in fertility preservation for cancer patients. Whether you are a survivor, an oncology care provider, a fertility specialist, a researcher, an AYA expert, an industry leader, an advocate, or have been personally touched by this issue in some way, someone on our Board or staff thought that you would want to stay in touch.
The Alliance for Fertility Preservation (the AFP) is a 501(c)(3) organization dedicated to expanding information and resources about fertility preservation for cancer patients and professionals. Under the leadership of our new Chairman,
Dr. Glenn Schattman, our team of fertility preservation experts has been working diligently to hone our focus and build new resources for you. We have launched our innovative online clinic locator and referral tool
Fertility Scout and we are increasing our efforts to expand coverage for fertility preservation services so that all patients might have access to the services they need. Learn more
about us.
We have many exciting initiatives taking shape this year, and we hope that you will join us as we work toward making parenthood after cancer a realistic and accessible goal for young adult cancer survivors.
|
|
Announcing our new members...
|
Our first order of business is to announce, with pride, new Members of our Board of Directors:
|
|
Lindsay Nohr Beck, an award-winning pioneer in the field of young adult oncology, is currently on a path to revolutionize the world of nonprofit fundraising by creating a marketplace for impact investing.
Lindsay started her nonprofit career as the founder of Fertile Hope (now a program of LIVESTRONG), a company she launched to address the profound reproductive needs of cancer patients and survivors - a need she discovered after her own experience with recurrent tongue cancer in her early 20s. Under Lindsay's leadership, Fertile Hope strategically integrated two disparate medical specialties by changing the standard of care and catalyzing the establishment of a new medical discipline now called "oncofertility." She has co-authored several papers on the subject, most notably ASCO's Fertility Preservation Guidelines, presented extensively around the world, and appeared in numerous media outlets, including the TODAY show, Wall Street Journal, New York Times, and SELF magazine. She is also the co-author of 100 Questions & Answers About Cancer and Fertility. Following the Fertile Hope acquisition, Lindsay led a groundbreaking initiative for LIVESTRONG to convince major insurance providers to reform healthcare benefits for cancer patients facing sterility from their treatment.
Lindsay earned her MBA at the Wharton School of the University of Pennsylvania in San Francisco. She lives in the San Francisco Bay Area with her husband and their four children.
|
Jennifer Levine is a pediatric oncologist and recognized expert in survivorship issues in pediatric survivors, including infertility. Dr. Levine oversees the provision of fertility preservation discussions and referrals within the Division of Pediatric Oncology and Stem Cell Transplant at Columbia University Medical Center.
She is the Principal Investigator, of the study "Ovarian Reserve in Adolescents with Lymphoma," a national study through the Children's Oncology Group. Dr. Levine has also been active in helping to standardize guidelines for fertility preservation for children, adolescents and young adults through the European Group PanCare and a member of the International Harmonization Guidelines section on female Fertility Preservation.
|
Joy Lewin is a highly accomplished pharmaceutical professional with innovative marketing talent spanning a 30-plus year career of proven results. The last 18 years have been focused primarily on Reproductive Health. Ms. Lewin is currently the Director of Commercial Development for Ferring Pharmaceuticals. She has also been actively involved as both Board Member of the American Infertility Association (2003-2007) and as the Chairman of the ASRM Industry Board Committee (2005-2007).
In 2013, she developed the "HeartBeat Program," which is designed to give newly diagnosed cancer patients the ability to access gonadotropins at no cost. Significantly, Ms. Lewin was the driving force for the creation of the AFP, and she is looking forward to being actively involved with the organization in her new role as a Member of the Board.
|
Lynn Westphal is a professor of Obstetrics and Gynecology at the Stanford University School of Medicine, where she is also the founder and Director of the Fertility Preservation Program.
Dr. Westphal's interest in fertility preservation for cancer survivors led her to set up one of the first oocyte cryopreservation programs in the country in 1999. She has held numerous national leadership positions, including being a past President of the Fertility Preservation Special Interest Group of the ASRM.
She graduated summa cum laude from Lawrence University, earned her M.D. degree at Stanford University, and did her residency training in obstetrics and gynecology at UCLA and Stanford University. She did a fellowship in molecular biology at Stanford University, and completed her fellowship in Reproductive Endocrinology and Infertility (REI) at UCSF.
As an AFP board member, she hopes to educate patients and clinicians and raise awareness for this important issue.
|
Please click here to view our new Board Officers and complete list of our Board Members:
View our Board!
|
|
|
|
 |
|
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
